Get 20% lifetime commission for referring investors to digrin.com
here.
SAB Biotherapeutics, Inc. ( SABS) - Key Metrics
SABS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.28 | -$0.30 | -$0.33 |
| 2026Q1 | $0 | -$0.35 | -$0.27 | -$0.28 |
| 2025Q4 | $0 | -$0.87 | -$0.87 | -$0.92 |
| 2025Q3 | $0 | $4.26 | -$1.22 | -$1.22 |
| 2025Q2 | $0 | -$1.09 | -$0.77 | -$0.77 |
SABS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.48 |
| 2026Q1 | 0% | -2.74 |
| 2025Q4 | 0% | -0.39 |
| 2025Q3 | 0% | 0.12 |
| 2025Q2 | 0% | -0.40 |
SABS
Price: $3.77
52 week price:
Earnings Per Share: 0.24 USD
P/E Ratio: 15.67
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 35000
Market Capitalization: 342.1 million